Intragastric Balloon Shell Materials for Extended Implant Duration
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current intragastric balloons have limited implant durations, typically up to six months, which is not sufficient for sustained therapeutic benefit in obesity treatment, and they face challenges with mechanical property degradation and infection resistance in the acidic stomach environment.
Innovation Solution
Development of an intragastric balloon with a shell made from 100% fluorinated room-temperature vulcanization (RTV) silicone or 15-30% phenyl-substituted high-temperature vulcanization (HTV) silicone materials, combined with a barrier and scaffold layer structure, providing improved mechanical properties, acid stability, and antimicrobial resistance, allowing for extended implantation periods of at least 9-12 months.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Duration of action of moving object
If conventional silicone materials are used in intragastric balloons, then the device can be implanted for up to six months, but the implant duration is insufficient for sustained therapeutic benefit in obesity treatment
Solution Approach 1:
The patent employs composite shell structures combining multiple materials: fluorinated RTV silicone (providing acid stability and infection resistance), phenyl-substituted HTV silicone (providing mechanical strength), and antimicrobial coatings. This composite approach enables the balloon to maintain structural integrity and resist degradation for 9-12 months in the harsh gastric environment, resolving the contradiction between extended implant duration and mechanical reliability.
Solution Approach 2:
The patent modifies material parameters by using fluorinated silicones with enhanced chemical stability and phenyl-substituted silicones with improved mechanical properties. These parameter changes in material composition allow the shell to withstand prolonged exposure to gastric acid and mechanical stress, enabling safe extension from 6 to 12 months implant duration while maintaining reliability.
2Duration of action of moving object
If the balloon is designed for longer implantation periods, then sustained therapeutic benefit is achieved, but resistance to mechanical degradation and infection in the acidic stomach environment becomes challenging
Solution Approach 1:
The patent uses composite shell structures combining fluorinated RTV silicone (providing acid stability and infection resistance), phenyl-substituted HTV silicone (providing mechanical strength), and antimicrobial coatings. This composite approach enables the balloon to maintain structural integrity and resist degradation for 9-12 months in the harsh gastric environment, resolving the contradiction between extended implant duration and mechanical reliability.
Solution Approach 2:
The patent incorporates antimicrobial coatings and designs the shell for controlled degradation after the therapeutic period, allowing the device to be replaced after 9-12 months. This approach manages the accumulation of harmful factors by designing the device lifecycle to prevent long-term infection risk while maintaining sustained therapeutic benefit during the active implant period.
3Device complexity
If conventional materials are used, then the device structure is simple, but the materials degrade mechanically and lose infection resistance over time
Solution Approach 1:
The patent employs composite shell structures combining multiple materials: fluorinated RTV silicone (providing acid stability and infection resistance), phenyl-substituted HTV silicone (providing mechanical strength), and antimicrobial coatings. This composite approach enables the balloon to maintain structural integrity and resist degradation for 9-12 months in the harsh gastric environment, resolving the contradiction between extended implant duration and mechanical reliability.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The new materials maintain structural integrity and reduce adverse events, enabling longer implant lifespans and improved therapeutic efficacy by resisting mechanical degradation and infection, thus providing a more durable and effective obesity treatment solution.
Implementation Method 1
The shell material of the Orbera® System balloon is a two-component high-temperature vulcanization (HTV) phenyl silicone with a platinum catalyzed curing system... Such a material has been proven suitable for implant durations of up to 6 months, but a material that permits implant for a year or longer would be desirable
Implementation Method 2
improved mechanical properties, acid stability, and antimicrobial resistance, allowing for extended implantation periods of at least 9-12 months
Implementation Method 3
improved mechanical properties, acid stability, and antimicrobial resistance, allowing for extended implantation periods of at least 9-12 months
Data Source
Figure 1~2
Figure 3
Figure 4
AI summary
An intragastric balloon with a 12-month lifespan. The intragastric balloon has a shell made of a material with as good as or better than initial mechanical properties of previous materials; i.e. higher ultimate tensile strength (UTS) and elongation at break (Eb), lower stiffness (K), higher acid stability, and improved resistance to infection. The new materials in particular provide improved acid resistance. These new materials produce a device that has reduced adverse events and a longer lifespan in vivo. The materials may form the entire wall of the shell or may form just a barrier layer coupled with a scaffold layer of a different material.